Gene Query: GDE1

Dataset Description Geneva Score
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 122.88
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 54.54
EP400 is required for Max and MCPyV mediated gene activation 33.81
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 30.24
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 30.06
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 29.74
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 29.2
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 26.67
TCF7L1 knockdown in pancreatic cancer 25.24
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 24.54
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 24.54
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 24.45
RNAseq of HEK293 cells after Chtop knockdown 23.61
Co-transcriptional loading of RNA export factors shapes the human transcriptome 23.61
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 23.05
SNHG5 siRNA knock down in HCT116 cells 21.95
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 20.93
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 20.79
Active translatome profiling with RiboLace in MCF7 cells 20.46
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 20.29
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 19.83
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 19.21
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 19.11
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 19.11
CHCHD2 gene KO effect in iPSC drived motor neurons 18.64
hnRNP C is a key regulator of protein synthesis in mitosis 18.51
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 18.43
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 18.43
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 18.33
Argonaute proteins couple chromatin silencing to alternative splicing 17.96
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 17.96
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 17.94
NRDE2 negatively regulates nuclear exosome functions 16.31
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 16.0
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 15.99
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 15.9
Targeting EZH2 in MYCN-amplified Neuroblastoma 15.9
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 15.85
Unique features and clinical importance of acute alloreactive immune responses 15.73
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 15.6
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 15.14
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 15.13
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 14.89
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 14.65
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.59
Seletive inhibition of CDK9 in DLBCL cell lines 14.03
Cajal bodies are linked to genome conformation 13.91
Cajal bodies are linked to genome conformation [RNA-Seq] 13.91
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 13.9
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 13.79
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 13.63
G-quadruplex structures mark human regulatory chromatin 13.6
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 13.57
Gene expression changes after LOC550643 silencing 13.48
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 13.41
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 13.28
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 13.25
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 13.25
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 13.21
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 13.12
Transcriptional effect of ETV1 knockdown in melanoma cells 13.1
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 12.95
Proliferation-correlated expression 12.82
Mitochondrial dsRNA triggers antiviral signalling in humans 12.77
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 12.67
An integrative analysis of non-coding regulatory DNA variations associated with autism 12.66
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 11.95
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 11.94
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 11.94
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 11.86
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 11.81
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 11.5
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 11.5
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 11.5
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 11.39
Differential analysis of gene regulation at transcript resolution by RNA-Seq 11.39
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 11.33
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.23
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 11.12
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.11
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.11
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.94
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.81
CHCHD10 gene KO effect in iPSC drived motor neurons 10.76
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 10.71
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 10.71
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 10.71
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 10.69
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 10.62
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 10.61
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 10.6
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.42
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 10.41
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 10.18
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 10.18
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 10.16
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 10.16
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 10.15
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 10.14
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 10.13
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 10.13
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 10.08
Expression level comparison under dividing and quiescent states in human primary fibroblasts 10.05
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 10.0
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 10.0
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 10.0
Gene expression profile of human iPSC-derived nephron progenitor cells 9.97
Transcriptomic analyssis following EHMT1/2 inhibition 9.8
Transcriptomic analysis of the HOTAIR-regulated genes 9.78
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 9.77
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 9.77
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 9.76
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 9.69
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 9.58
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 9.58
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.54
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.5
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.42
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 9.41
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 9.3
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 9.24
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 9.23
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 9.2
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 9.11
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 9.11
HNRNPL and its RNA Targets in Prostate Cancer 9.11
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 9.09
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.06
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.05
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 9.02
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 9.02
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.01
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.01
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 8.96
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.83
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 8.78
Developmental stage specific chromosome architecture in human erythroid cells 8.77
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.77
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.72
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 8.69
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 8.64
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 8.63
T47D RNA-seq and ChrRNA-seq data 8.63
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.63
Systematic discovery of endogenous human ribonucleoprotein complexes 8.61
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 8.55
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 8.52
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 8.47
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.45
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 8.45
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 8.4
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 8.36
RNA-seq of shEZH2 cells 8.35
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.35
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.27
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 8.27
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.21
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 8.21
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 8.17
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 8.12
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 8.09
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 8.09
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 8.09
Non-coding regions are the main source of tumor-specific antigens 8.06
Non-coding regions are the main source of tumor-specific antigens [human] 8.06
Transcriptional profiling of LS1034 cells treated with tepoxalin 8.05
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.04
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 8.0
Global analysis of alternative splicing regulated by RBM10 7.96
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.92
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.83
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 7.82
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 7.77
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 7.73
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 7.73
Total RNA-seq in ALL-SIL upon JQ1 inhibition 7.72
Inhibition of TNBC metastasis by Gpx1 7.69
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 7.66
Genome-wide analysis of the Integrator complex 7.59
Genome-wide analysis of the Integrator complex (HTS) 7.59
RNA editing in nascent RNA affects pre-mRNA splicing 7.58
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.58
RNA-seq of young and quiescent MRC-5 human fibroblasts 7.55
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 7.54
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 7.54
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.52
Transcriptome analysis of kidney organoids 7.49
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 7.47
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.46
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.39
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.36
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 7.33
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 7.3
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.11
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 7.09
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 7.09
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.09
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 7.08
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 7.05
Nonpregnant and term pregnant human myometrial tissues 7.05
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 7.04
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.99
RNA-sequencing in immortalized human mammary epithelial cells 6.97
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.97
RNA-Seq with and without RNase treatment in PCa cell lines 6.95
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.94
Illumina Total RNA-seq in HeLa 6.94
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.93
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 6.93
Ebola virus (EBOV) infection of ARPE-19 cells 6.92
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 6.9
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 6.9
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 6.87
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 6.86
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 6.81
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.77
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.77
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 6.75
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.75
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.75
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.75
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 6.71
Postnatal lipids drive hepatocyte maturation 6.7
Differential Gene Expression between MCF10A and MCF7 cells 6.7
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 6.69
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.67
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.66
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.65
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 6.64
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.63
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.62
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 6.6
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.6
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.6
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 6.56
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 6.56
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.52
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.52
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.51
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.44
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 6.44
Hypoxic transcriptome of SQ20B human head and neck cancer cells 6.42
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.4
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.38
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 6.38
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 6.38
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 6.36
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 6.36
Tpl-2 and MEK small molecule inhibitors 6.36
Tpl-2 small molecule project 6.36
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 6.34
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 6.33
Effect of BMP inhibition or stimulation of primary human keratinocytes 6.33
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 6.3
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 6.3
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.27
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.27
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 6.25
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 6.25
Genome-wide analysis of Dengue virus 2 infected cells 6.25
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 6.22
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 6.17
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 6.16
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 6.13
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 6.11
RNA transcriptome analysis during HSV-1 infection 6.03
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.03
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.02
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.01
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.95
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.91
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.9
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.85
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 5.83
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 5.83
MRTF activates TEAD-YAP target gene expression 5.83
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 5.82
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 5.8
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 5.8
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 5.8
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 5.78
BET bromodomain inhibition 5.78
MARS Seq data from human cortical organoids 5.75
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 5.75
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 5.75
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 5.75
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.75
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.7
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.69
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.66
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 5.65
Effect of ILF3 on translation during homeostasis and the antiviral response 5.59
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  5.59
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.52
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 5.48
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.45
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.44
Peptidomimetic blockade of MYB in acute myeloid leukemia 5.43
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 5.43
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 5.4
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 5.4
Real-time observation of light-controlled transcription in living cells 5.4
TFAP2C signalling in human fibroblasts 5.37
Characterization of human ILC2 subsets 5.37
RNA Seq of HMVEC under hypoxia 5.28
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 5.28
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.18
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.14
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 5.1
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.09
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 5.09
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 5.04
Transcriptome of Stabilin-1 siRNA transfected human monocytes 5.01
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.94
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 4.91
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 4.88
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.86
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.72
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.72
PRDM1 inhibits proliferation of human colon cancer organoids 4.66
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 4.58
Gene Expression Profiling of WT and KDM3A Knocked out Cell 4.58
Genome-wide discovery of human splicing branchpoints 4.58
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 4.57
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.57
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.55
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 4.53
Effect of nuclear IL-33 on gene expression 4.51
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 4.49
Genome-wide discovery of human splicing branchpoints [RNAse] 4.47
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.43
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 4.42
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.41
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.4
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 4.38
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.37
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 4.23
RNA-seq of RKO cells with cTAZ KO or putback 4.19
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.17
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.16
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.16
RNA sequencing of human mammary epithelial cells 4.15
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 4.15
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.14
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 4.14
Sensing self and nonself circular RNAs 4.11
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 4.08
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 4.06
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.06
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.02
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.01
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 4.0
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.94
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.94
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.91
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.87
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 3.75
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 3.66
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 3.66
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.64
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.64
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.64
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.61
Activity-dependent transcriptional changes in human neurons 3.52
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.52
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.51
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.51
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.51
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 3.47
Transcriptome analysis of CNS leukemia 3.4
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.4
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 3.4
Dilated cardiomyopathy vs Myocarditis 3.36
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 3.34
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.31
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.27
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.27
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 3.24
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 3.15
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.15
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 3.15
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.12
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.06
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.02
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.85
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.85
A single-cell transcriptome atlas of the human pancreas 2.85
U2AF1 mutations alter splice site recognition in hematological malignancies 2.82
Metabolism as an early predictor of DPSCs aging 2.82
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 2.81
RNA Sequencing of Human iPS derived Cardiomyocytes 2.74
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.73
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 2.73
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.72
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.72
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.67
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.64
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.64
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.64
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.63
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.63
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.51
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 2.36
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.36
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.36
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.34
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.33
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.3
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.28
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.27
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.25
Functional significance of the HIV-1 Tat signature amino acid residues 2.25
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.2
Gene expression profiling of KSHV-infected periodontal ligament cells 2.19
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.16
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.14
The Genetic Landscape of Diamond-Blackfan Anemia 2.12
Transcriptome analysis upon C6orf203 silencing 2.12
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.1
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.09
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 2.08
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.03
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.03
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.97
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.96
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.94
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.82
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.8
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.79
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 1.74
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.69
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.67
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.54
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 1.54
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.51
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.5
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.5
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.44
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.43
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.33
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.31
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.31
Transposon-based construction of strand-specific RNA-seq libraries 1.29
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.27
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.26
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.14
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.09
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.09
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.08
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.03
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.02
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.02
Identification of a LIF-responsive replication-competent human β cell 1.01
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.99
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.96
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.9
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.89
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.88
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.87
Modeling Human Cancer-induced Cachexia (Human) 0.85
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.78
Enhancer activation during EGF response 0.77
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.73
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.71
Loss of CREBBP results in gene expression repression in lymphoma cells 0.71
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.7
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.69
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.67
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.6
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.58
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.56
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.52
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.51
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.51
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.51
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.44
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.42
Determining mRNA half-lives on a transcriptome-wide scale 0.4
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.34
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.34
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.32
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.3
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.3
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.29
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.27
RNAseq of Breast cancer PDX samples 0.23
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.23
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.12
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.12
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.12
Preclinical model of obesity and ER-positive breast cancer 0.09
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.09
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.06
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.06
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.06
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.06
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.03
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.01
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation